DailyStocks Stock Article Search

567 Spam-Free Article(s) Found

Sort:

Date

Filter:

All

DeepLinks

Symbol	Name	Last Close	Mkt Cap	DailyStocks' Rating Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.	Vote Now! Monday’s Close
MS	Morgan Stanley	$47.68	$83.19B	Uptrend	Up Down

Article Searches

https://seekingalpha.com/news/3447073-fda-oks-merck-kgaas-ms-med-mavenclad?source=feed_news_all Mar 30, 2019 - The FDA approves Merck KGaA (OTCPK:MKGAY) unit EMD Serono's Mavenclad (cladribine) tablets for the treatment of relapsing forms of multiple sclerosis (MS).Because of its safety profile, the dr 0

http://www.zacks.com/stock/news/365815/novartis-nvs-receives-fda-approval-for-ms-drug-mayzent?cid=CS-ZC-FT-365815 Mar 27, 2019 - Novartis (NVS) obtains FDA approval for Mayzent for the treatment of relapsing forms of MS. 0

http://www.zacks.com/stock/news/365034/celgene-celg-submits-nda-for-ms-drug-to-fda-for-review?cid=CS-ZC-FT-365034 Mar 26, 2019 - Celgene (CELG) progresses with the development of its MS candidate, as it submits an application for the same to the FDA. 0

https://seekingalpha.com/news/3445524-celgene-files-u-s-application-ms-med-ozanimod?source=feed_news_all Mar 25, 2019 - Celgene (NASDAQ:CELG) has filed a marketing application with the FDA seeking approval for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (MS).It filed an appli 0

http://www.zacks.com/stock/news/362828/williams-wmb-forms-marcellus-utica-jv-with-canadian-fund?cid=CS-ZC-FT-362828 Mar 21, 2019 - Williams (WMB) creates a $3.8-billion partnership with Canada Pension Plan Investment Board in the western Marcellus and Utica basins. 0

http://www.zacks.com/stock/news/362608/stock-market-news-for-mar-21-2019?cid=CS-ZC--362608 Mar 21, 2019 - Wall Street was mostly lower on Wednesday following decline in bank stocks after the Fed decided not to hike rate in 2019. 0

https://www.fool.com/investing/2019/03/20/fang-stocks-what-to-expect-in-2019.aspx?source=iedfolrf0000001 Mar 20, 2019 - This group of high-flying tech stocks has crushed the market in recent years. Will the good times continue? 0

http://www.sandiegouniontribune.com/business/sd-me-ozanimod-celgene-receptos-scripps-20190313-story.html Mar 13, 2019 -

Ozanimod, a drug for multiple sclerosis originating at Scripps Research, has been submitted for European approval by Celgene.

A U.S. Food and Drug Administration marketing application is also on track for filing by the end of March, the New Jersey-based drug company said Monday. The FDA rejected...

http://www.zacks.com/research-daily/359113/top-analyst-reports-for-procter-gamble-netflix-costco?cid=CS-ZC-FT-359113 Mar 13, 2019 - Top Analyst Reports for Procter & Gamble, Netflix & Costco 0

http://www.zacks.com/stock/news/358951/celgene-celg-submits-application-for-ms-drug-in-europe?cid=CS-ZC-FT-358951 Mar 12, 2019 - Celgene (CELG) submits application for MS drug, ozanimod to the European Medicines Agency. 0

Pages: 123 4 5 6 7...57